WIPO Re:Search Gains Momentum in the Fight Against Neglected Tropical Diseases, Malaria and Tuberculosis
WIPO Re:Search signed on more than a dozen new members in 2014, including two leading pharmaceutical firms, and nearly doubled the number of research agreements using shared intellectual property to promote the fight against neglected tropical diseases, tuberculosis and malaria. Click here for the full press release from WIPO.
BVGH Presented Ebola Overview at Addis Ababa Meeting
BVGH developed and presented an overview of products in development for Ebola virus disease including drugs, vaccines and diagnostics, at a meeting convened by the African Network for Drugs and Diagnostics Innovation (ANDI) in Addis Ababa, Ethiopia on January 20, 2015. Dr. Solomon Nwaka, Executive Director, ANDI, convened a high level meeting of African Health Leaders, Researchers, Policy Directors, Funders and Industry to present Africa’s innovation and efforts to address the Ebola epidemic. Jennifer Dent, President, BVGH presented the Ebola pipeline. She also chaired a panel session with industry leaders, exploring the opportunities and challenges partnerships present when working across sectors, cultures and with governments to achieve a global health objective. Learn more about the ANDI meeting, and ANDI strategic objectives here.
2014 WIPO Re:Search Partnership Hub Report
The 2014 Partnership Hub Report presents the global reach of WIPO Re:Search collaborations and the diseases and products they focus on. Browse through the report to see WIPO Re:Search agreement, recruitment, and communication details and scroll to page 10 to view the status of all WIPO Re:Search collaborations established through 2014.
GAFFI and BVGH Convening Global Fungal Infection Forum
The Global Action Fund for Fungal Infections (GAFFI) has partnered with BIO Ventures for Global Health (BVGH) to develop a report outlining a 10-year road map on the burden of opportunistic fungal infections, funding and gaps. To achieve this goal, GAFFI and BVGH are hosting an international meeting, the Global Fungal Infection Forum, in Seattle, USA on February 22, 2015. This forum will convene key fungal infection stakeholders. The Global Fungal Infection Forum will focus on four fungal infections that represent the greatest mortality burden in the developing world. Learn more about the meeting.
Merck KGaA Joins WIPO Re:Search
Merck KGaA has joined WIPO Re:Search. As the co-developer of praziquantel, Merck KGaA has long been involved in global health R&D. This continues Merck KGaA's commitment to finding solutions for unmet medical needs of the developing world. Learn more about WIPO Re:Search.
New Publication on WIPO Re:Search Antihelmintic Development Collaborations
A new review by BVGH on how WIPO Re:Search has accelerated the development of antihelmintic drug discovery through eleven collaborations has been published in the International Journal for Parasitology. To read or download this and other BVGH publications, visit Reports and Publications.